Interactions between 2,3,7,8-TCDD and PCBs as tumor promoters: Limitations of TEFs

Teratogenesis Carcinogenesis and Mutagenesis

Volumn 17, Issue 4-5, 1997, Pages 217-224

  Wölfle, Detlef ^a  

^a UNIVERSITY OF HAMBURG   (Germany)

Author keywords

Additive and antagonistic effects; Carcinogenicity; Dioxin; Polychlorinated biphenyls; TEFs

Indexed keywords

BIPHENYL; DIOXIN; FURAN DERIVATIVE; POLYCHLORINATED BIPHENYL; TEPA; TUMOR PROMOTER;

ANIMAL EXPERIMENT; CARCINOGENICITY; CONFERENCE PAPER; CONTROLLED STUDY; LIGAND BINDING; MALIGNANT TRANSFORMATION; NONHUMAN; PRIORITY JOURNAL; RISK ASSESSMENT; TERATOGENESIS; TUMOR PROMOTION;

ANIMALS; CARCINOGENS; CELL TRANSFORMATION, NEOPLASTIC; CELLS, CULTURED; MICE; MICE, INBRED C3H; POLYCHLORINATED BIPHENYLS; TETRACHLORODIBENZODIOXIN;

EID: 2642692706     PISSN: 02703211     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1520-6866(1997)17:4/5<217::AID-TCM4>3.0.CO;2-L     Document Type: Conference Paper

References (36)

1. Pitot HC, Goldsworthy T, Moran S, Kennan W, Glauert HP, Maronpot R, Campbell HA: A method to quantitate the relative initiating and promoting potencies of hepalocarcinogenic agents in their dose-response relationships to altered hepatic foci. Carcinogenesis 8:1491-1499, 1987.
2. Huff J, Lucier G, Tritscher A: Carcinogenicity of TCDD: Experimental, mechanistic, and epidemiologic evidence. Annu Rev Pharmacol Toxicol 34:343-372, 1994.
3. Tritscher AM, Seacat AM, Yager JD, Groopman JD, Miller BD, Bell D, Sutter TR, Lucier GW: Increased oxidative DNA damage in livers of 2,3,7,8-tetrachlorodibenzo-p-dioxin trealed intact but not ovariectomized rats. Cancer Lett 98:219-225, 1996.
4. Clarke G, Tritscher A, Maronpot R, Foley J, Lucier G: Tumor promotion by TCDD in female rats. In: "Biological Basis for Risk Assessment of Dioxins and Related Compounds." Banbury Report 35, Cold Spring Harbor, NY: Cold Spring Harbor Press, 1991, pp 389-404.
5. Kociba RJ, Keyes DG, Beyer JE, Carreaon RE, Wade EE, Dillenber DA, Kalnins RP, Fauson LE, Parks CN, Barnard SD, Hummel RA, Humitson CG: Results of a two-year chronic toxicity and oncogenicily study of 2,3,7,8-tetrachlorodibenzo-p-dioxin in rats. Toxicol Appl Pharmacol 46:279-293, 1978.
6. Gierthy JF, Bennett JA, Bradley LM, Cutler DS: Correlation of in vitro and in vivo growth suppression of MCF-7 human breast cancer by 2,3,7,8-tetrachlorodibenzo-p-dioxin. Cancer Res 53:3149-3153, 1993.
7. Beebe LE, Fornwald LW, Diwan BA, Anver MR, Anderson LM: Promotion of N-nitrosodiethylamine-initiated hepatocellular tumors and hepatoblastomas by 2,3,7,8-tetrachlorodibenzo-p-dioxin or Aroclor 1254 in C57BL76, DBA/2, and B6D2F1 mice. Cancer Res 55:4875-4880, 1995.
8. Harris M, Zacharewski T, Safe S: Comparative potencies of Aroclor 1232, 1242, 1248, 1254, and 1260 in male Wistar rats: Assessment of the toxic equivalency factor (TEF) approach for polychlorinated biphenyls (PCBs). Fundam Appl Toxicol 20:456-463, 1993.
9. Gradin K, McGuire J, Wenger H, Kvietikova I, Whitelaw ML, Toftgard R, Tora L, Gassmann M, Pellinger L: Functional interference between hypoxia and dioxin signal transduction pathways: Competition for recruitment of the Arnt transcription factor. Mol Cell Biol 16:5221-5231, 1996.
10. Pimentai RA, Liang B, Yee GK, Wilhelmsson A, Poellinger L, Paulson KE: Dioxin receptor and C/ EBP regulate the function of the glutathion S-transferase Ya gene xenobiotic response element. Mol Cell Biol 13:4365-4373, 1993.
11. Carrier F, Chang C-Y, Duh J-L, Nebert DW, Puga A: Interaction of the regulatory domains of the murine Cyp1a1 gene with two DNA-binding proteins in addition to the Ah receptor and the Ah receptor nuclear translocator (ARNT). Biochem Pharmacol 48:1767-1778, 1994.
12. Matsumura F: How important is the protein phosphorylation pathway in the toxic expression of dioxin-type chemicals? Biochem Pharmacol 48:215-224, 1994.
13. Kraemer SA, Arthur KA, Denison MS, Smith WL, Dewitt DL: Regulation of prostaglandin endoperoxide H synthase-2 expression by 2,3,7,8-tetrachlorodibenzo-p-dioxin. Arch Biochem Biophys 330:319-328, 1996.
14. 2 promoter activity are localized to the TATA box binding region and controlled through a tyrosine kinase-dependent pathway. Toxicol Appl Pharmacol 137:90-99, 1996.
15. Puga A, Nebert DW, Carrier F: Dioxin induces expression of c-fos and c-jun protooncogenes and a large increase in transcription factor AP-1. DNA Cell Biol 11:269-281, 1992.
16. Rininger J, Ma X, Babish JG: Increased hepatic expression and phosphorylation of the murine p53 tumor suppressor protein and expression of p21WAF1 CDK-inhibitory protein following acute dosing of TCDD. Organohalogen Compounds 25:367-372, 1995.
17. Fox TR, Best LL, Goldsworthy SM, Mills JJ, Goldsworthy TL: Gene expression and cell proliferation in rat liver after 2,3,7,8-tetrachlorodibenzo-p-dioxin exposure. Cancer Res 53:2265-2271, 1993.
18. Jungermann K, Probst I, Andersen B, Wölfle D: Significance of substrates, hormones and hepatocyte heterogeneity for the regulation of hepatic glycolysis and gluconeogenesis. In Harris RA, and Cornell NW, eds: "Isolation, Characterization and Use of Hepatocytes." New York: Elsevier-North Holland, 1983, pp 125-130.
19. Schrenk D, Buchmann A, Dietz K, Lipp H-P, Brunner H, Sirma H, Münzel P, Hagenmaier H, Gebhardt R, Bock KW: Promotion of preneoplastic foci in rat liver with 2.3.7.8-tetrachlorodibenzo-p-dioxin, 1,2,3,4,7,8-heptachlorodibenzo-p-dioxin and a defined mixture of 49 polychlorinated dibenzo-p-dioxins. Carcinogenesis 15:509-515, 1994.
20. Waern F, Flodström S, Busk L, Kronevi T, Nordgren I, Ahlborg UG: Relative liver tumor promoting activity and toxicity of some polychlorinated dibenzo-p-dioxin-and dibenzofuran-congeners in female Sprague-Dawley rats. Pharmacol Toxicol 69:450-458, 1991.
21. Hemming H, Bager Y, Flodström S, Nordgren I, Kronevi T, Ahlborg UG, Wärngard L: Liver tumor promoting activity of 3,4,5,3′,4′-pentachlorobiphenyl and its interaction with 2,3,7,8-tetrachlorodibenzo-p-dioxin. Eur J Pharmacol 292:241-249, 1995.
22. Sargent L, Sattler GL, Roloff B, Xu Y, Sattler CA, Meisner L, Pitot HC: Ploidy and specific karyotypic changes during promotion with phenobarbital, 2,5,2′,5′-tetrachlorobiphenyl, and/or 3,4,3′,4′-tetrachlorobiphenyl in rat liver. Cancer Res 52:955-962, 1992.
23. Van der Plas S, Brouwer A, Haag-Grönlund M, Wärngard L, Ahlborg UG: Non-additive induction of altered hepatic foci in female Sprague Dawley rats by a mixture of dioxin-like compounds. Organohalogen Compounds 29:233-237, 1996.
24. Hemming H, Flodström S, Wärngard L, Bergman A, Kronevi T, Nordgren I, Ahlborg UG: Relative tumor promoting activity of three polychlorinated biphenyls in rat liver. Eur J Pharmacol 248:163-174, 1993.
25. Bager Y, Hemming H, Flodström S, Ahlborg UG, Wärngard L: Interaction of 3,4,5,3′,4′-pentachlorobiphenyl and 2,4,5,2′,4′,5′-hexachlorobiphenyl in promotion of altered hepatic foci in rats. Pharmacol Toxicol 77:149-154, 1995.
26. Berberian I, Chen LC, Robinson FR, Glauert HP, Chow CK, Robertson LW: Effect of dietary retinyl palmitate on the promotion of altered hepatic foci by 3,3′,4,4′-tetrachlorobiphenyl and 2,2′,4,4′,5,5′-hexachlorobiphenyl in rats initiated with diethylnitrosamine. Carcinogenesis 16:393-398, 1995.
27. Biegel L, Harris M, Davis D, Rosengren R, Safe L, Safe S: 2,2′,4,4′,5,5′-Hexachlorobiphenyl as a 2,3,7,8-tetrachlorodibenzo-p-dioxin antagonist in C57BL/6J mice. Toxicol Appl Pharmacol 97:561-571, 1989.
28. Wölfle D, Marquardt H: Antioxidants inhibit the enhancement of malignant cell transformation induced by 2,3,7,8-tetrachlorodibenzo-p-dioxin. Carcinogenesis 17:1273-1278, 1996.
29. Merchant M, Krishnan V, Safe S: Mechanism of action of α-naphthoflavone as an Ah receptor antagonist in MCF-7 human breast cancer cells. Toxicol Appl Pharmacol 120:179-185, 1993.
30. Wölfle D, Kähler A, Marquardt H: Assessment of the cytotoxic and tumor promoting potential of 2,3,7,8-TCDD and PCB congeners in vitro: Comparison of in vitro and in vivo data. Organohalogen Compounds 25:195-198, 1995.
31. Marnett LJ: Aspirin and the potential role of prostaglandins in colon cancer. Cancer Res 52:5575-5589, 1992.
32. Wölfle D, Schäfer W, Marotzki S, Marquardt H: The promotion of malignant transformation of mouse fibroblasts in vitro by 2,3,7,8-TCDD is associated with changes in the arachidonic acid metabolism. Organohalogen Compounds 29:238-241, 1996.
33. Marotzki S, Wölfle D, Marquardt H: Enhanced transcription of cyclooxygenases is associated with the 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced promotion of malignant transformation of mouse fibroblasts in vitro. Naunyn Schmiedeberg's Arch Pharmacol 355 (Suppl.):580, 1997.
34. Subbaramaiah K, Telang N, Ramonetti JT, Araki R, DeVito B, Weksler BB, Dannenberg AJ: Transcription of cyclooxygenase-2 is enhanced in transformed mammary epithelial cells. Cancer Res 56:4424-4429, 1996.
35. Ma X, Mufti NA, Babish JG: Protein tyrosine phosphorylation as an indicator of 2,3,7,8-tetrachlorodibenzo-p-dioxin exposure in vivo and in vitro. Biochem Biophys Res Commun 189:59-65, 1992.
36. Matsumura F, Tullis K, Enan E, Bombick W, Olsen H: Stimulation of c-ras expression of 2,3,7,8-tetrachlorodibenzo-p-dioxin. Chemosphere 25:959-966, 1992.